T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement

Journal of Neuroimmunology

Volumn 235, Issue 1-2, 2011, Pages 27-32

  Saadoun, Samira ^a   Waters, Patrick ^b   MacDonald, Claire ^a   Bridges, Leslie R ^a   Bell, B Anthony ^a   Vincent, Angela ^b   Verkman, A S ^c,d   Papadopoulos, Marios C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aquaporin 4; Devic's syndrome; Lymphocytes; NMO; T cells

Indexed keywords

AQUAPORIN 4; CD45 ANTIGEN; COMPLEMENT; IMMUNOGLOBULIN G; MYELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MOUSE; MYELOOPTIC NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; T CELL DEPLETION; WILD TYPE;

ANIMALS; BRAIN; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC DEFICIENCY SYNDROMES; INJECTIONS, INTRAVENTRICULAR; MICE; MICE, KNOCKOUT; MICE, NUDE; NEUROMYELITIS OPTICA; T-LYMPHOCYTES;

EID: 79957993247     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.03.007     Document Type: Article

References (21)

1. Bennett J.L., Lam C., Kalluri S.R., Saikali P., Bautista K., Dupree C., Glogowska M., Case D., Antel J.P., Owens G.P., Gilden D., Nessler S., Stadelmann C., Hemmer B. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann. Neurol. 2009, 66:617-629.
2. Bradl M., Misu T., Takahashi T., Watanabe M., Mader S., Reindl M., Adzemovic M., Bauer J., Berger T., Fujihara K., Itoyama Y., Lassmann H. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 2009, 66:630-643.
3. Cunliffe V.T., Furley A.J., Keenan D. Complete rescue of the nude mutant phenotype by a wild-type Foxn1 transgene. Mamm. Genome 2002, 13:245-252.
4. Fletcher J.M., Lalor S.J., Sweeney C.M., Tubridy N., Mills K.H. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 2010, 162:1-11.
5. Hinson S.R., Pittock S.J., Lucchinetti C.F., Roemer S.F., Fryer J.P., Kryzer T.J., Lennon V.A. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69:2221-2231.
6. Jacob A., Weinshenker B.G., Violich I., McLinskey N., Krupp L., Fox R.J., Wingerchuk D.M., Boggild M., Constantinescu C.S., Miller A., De Angelis T., Matiello M., Cree B.A. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch. Neurol. 2008, 65:1443-1448.
7. Jarius S., Paul F., Franciotta D., Waters P., Zipp F., Hohlfeld R., Vincent A., Wildemann B. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat. Clin. Pract. Neurol. 2008, 4:202-214.
8. Kindred B. Nude mice in immunology. Prog. Allergy 1979, 26:137-238.
9. Kinoshita M., Nakatsuji Y., Moriya M., Okuno T., Kumanogoh A., Nakano M., Takahashi T., Fujihara K., Tanaka K., Sakoda S. Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. Neuroreport 2009, 20:508-512.
10. Kira J. Neuromyelitis optica and opticospinal multiple sclerosis: mechanisms and pathogenesis. Pathophysiology 2010, 18:69-79.
11. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., Nakashima I., Weinshenker B.G. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
12. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 2005, 202:473-477.
13. Lucchinetti C.F., Mandler R.N., McGavern D., Bruck W., Gleich G., Ransohoff R.M., Trebst C., Weinshenker B., Wingerchuk D., Parisi J.E., Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461.
14. Miyamoto K., Kusunoki S. Intermittent plasmapheresis prevents recurrence in neuromyelitis optica. Ther. Apher. Dial. 2009, 13:505-508.
15. Roemer S.F., Parisi J.E., Lennon V.A., Benarroch E.E., Lassmann H., Bruck W., Mandler R.N., Weinshenker B.G., Pittock S.J., Wingerchuk D.M., Lucchinetti C.F. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130:1194-1205.
16. Saadoun S., Bell B.A., Verkman A.S., Papadopoulos M.C. Greatly improved neurological outcome after spinal cord compression injury in AQP4-deficient mice. Brain 2008, 131:1087-1098.
17. Saadoun S., Tait M.J., Reza A., Davies D.C., Bell B.A., Verkman A.S., Papadopoulos M.C. AQP4 gene deletion in mice does not alter blood-brain barrier integrity or brain morphology. Neuroscience 2009, 161:764-772.
18. Saadoun S., Waters P., Anthony Bell B., Vincent A., Verkman A.S., Papadopoulos M.C. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010, 133:349-361.
19. Waters P., Jarius S., Littleton E., Leite M.I., Jacob S., Gray B., Geraldes R., Vale T., Jacob A., Palace J., Maxwell S., Beeson D., Vincent A. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch. Neurol. 2008, 65(7):913-919.
20. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6:805-815.
21. Wuthrich C., Kesari S., Kim W.K., Williams K., Gelman R., Elmeric D., De Girolami U., Joseph J.T., Hedley-Whyte T., Koralnik I.J. Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells. J. Neurovirol. 2006, 12:116-128.